TMS vs ECT: Comparing Two Brain Stimulation Treatments for Depression
TMS vs ECT: Comparing Two Brain Stimulation Treatments for Depression
At a Glance
- Both TMS (transcranial magnetic stimulation) and ECT (electroconvulsive therapy) are FDA-cleared brain stimulation treatments for depression that has not responded to medication.
- ECT remains the most effective treatment for severe, treatment-resistant depression, with response rates of 50 to 70%. TMS response rates range from 50 to 60%, with lower remission rates.
- ECT requires general anesthesia, can cause short-term memory loss (and occasionally longer-term cognitive effects), and carries higher procedural risk. TMS is performed awake, causes minimal side effects (primarily headache), and does not affect memory.
- TMS is typically the first-line brain stimulation option for treatment-resistant depression, while ECT is reserved for severe cases, catatonia, or situations requiring rapid response.
- Cost for a full TMS course: $6,000 to $12,000. Cost for a full ECT course: $25,000 to $50,000+. Insurance covers both in most cases.
When antidepressants and therapy have not produced adequate relief, brain stimulation becomes part of the conversation. Two treatments dominate this space: transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT). Both are FDA-cleared, both have strong evidence behind them, and both fill a real gap in depression treatment for the roughly one-third of patients who do not respond adequately to medication.
But TMS and ECT are very different treatments in terms of how they work, what the experience is like, the side effects they carry, and who qualifies for each. If you are weighing these options (or if a doctor has recommended one), this guide breaks down the comparison in plain terms so you can make an informed decision.
How Each Treatment Works
TMS: Magnetic Pulses to Targeted Brain Regions
Transcranial magnetic stimulation uses a magnetic coil placed against the scalp to deliver focused magnetic pulses to specific regions of the brain. For depression, the primary target is the left dorsolateral prefrontal cortex (DLPFC), a region consistently shown to be underactive in depressed patients. The magnetic pulses induce small electrical currents in the targeted neurons, increasing their activity and restoring function in circuits involved in mood regulation.
TMS does not require anesthesia or sedation. You sit in a chair, awake and alert, while the coil is positioned on your head. Each session lasts 3 to 40 minutes depending on the protocol used. Standard repetitive TMS (rTMS) takes about 37 minutes per session. The newer theta burst stimulation (TBS) protocol condenses the treatment into roughly 3 minutes per session with comparable efficacy. The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) protocol, which delivers multiple TBS sessions per day over five days, has shown remission rates exceeding 78% in initial studies.
A standard TMS course consists of 36 sessions delivered over six to nine weeks (five sessions per week for the first six weeks, then a taper). For more detail on the treatment process, see our TMS therapy guide.
ECT: Controlled Electrical Seizure Under Anesthesia
Electroconvulsive therapy delivers a brief, controlled electrical current through the brain to induce a generalized seizure lasting 30 to 60 seconds. The procedure is performed under general anesthesia with a muscle relaxant, so the patient is unconscious and does not physically convulse. The seizure itself is monitored via EEG and is believed to produce its therapeutic effect by triggering widespread changes in brain chemistry, including increases in BDNF (brain-derived neurotrophic factor), alterations in neurotransmitter systems, and changes in brain connectivity.
ECT has been in use since the 1930s, though modern ECT bears little resemblance to the dramatized portrayals in films. Current techniques use brief-pulse or ultra-brief-pulse stimulation, precise electrode placement (right unilateral vs. bitemporal), and careful anesthesia protocols to maximize efficacy while minimizing cognitive side effects.
A typical acute ECT course involves 6 to 12 sessions delivered two to three times per week over three to four weeks. Some patients require maintenance ECT (weekly to monthly sessions) to sustain improvement.
Efficacy: Head-to-Head Comparison
| Measure | TMS | ECT |
|---|---|---|
| Response rate (50%+ symptom reduction) | 50-60% | 50-70% (higher in some studies: up to 80%) |
| Remission rate | 25-35% (standard rTMS); up to 78% (SAINT protocol) | 30-50% |
| Speed of response | 2-4 weeks (standard); 5 days (SAINT) | 1-2 weeks (faster onset overall) |
| Durability | Varies; some patients need maintenance sessions | High relapse without maintenance; 50%+ relapse within 6 months without continuation |
| Evidence level | Strong (FDA-cleared; multiple RCTs) | Very strong (largest evidence base of any depression treatment after medication) |
ECT holds a slight edge in overall response rates, particularly for the most severe, treatment-resistant cases. It also tends to work faster, which is why it remains the treatment of choice for psychiatric emergencies such as severe depression with active suicidality, catatonia, or psychotic depression. However, the SAINT protocol for TMS has shown remarkably high remission rates in initial studies, and if those results are replicated in larger trials, the efficacy gap may narrow considerably.
One important distinction: response rates depend heavily on how treatment-resistant the patient population is. In patients who have failed one or two medications, TMS performs well. In patients who have failed four or more medications, ECT tends to outperform TMS.
Side Effects: Where the Differences Are Sharpest
This is where TMS and ECT diverge most dramatically, and for many patients, side effects are the deciding factor.
TMS Side Effects
- Scalp discomfort or pain at the stimulation site: The most common side effect, reported by 30 to 50% of patients. Usually mild to moderate and decreasing over sessions as patients acclimate.
- Headache: Reported by about 20 to 30% of patients. Typically responds to over-the-counter pain relievers.
- Lightheadedness: Occasional and brief.
- Facial twitching: During treatment only, caused by magnetic pulse stimulating nearby facial muscles.
- Seizure risk: Extremely rare (less than 0.1% with standard protocols). TMS is considered safe for most patients.
- No cognitive effects: TMS does not cause memory loss, confusion, or any measurable cognitive impairment.
ECT Side Effects
- Short-term memory loss: The most significant side effect. Most patients experience some degree of retrograde amnesia (difficulty recalling events from the weeks surrounding treatment) and anterograde amnesia (difficulty forming new memories during the treatment period). For the majority of patients, these effects resolve within weeks to months after completing ECT.
- Longer-term memory effects: A subset of patients (estimates vary from 10 to 30%) report persistent memory difficulties that extend beyond the acute treatment period. This is the most controversial aspect of ECT, and researchers continue to work on protocols that minimize cognitive risk. Right unilateral electrode placement with ultra-brief pulse width causes less memory disruption than bitemporal placement.
- Confusion: Post-treatment confusion is common immediately after waking from anesthesia and usually clears within an hour.
- Headache, muscle aches, nausea: Related to anesthesia and the seizure itself. Usually manageable with medication.
- Anesthesia risks: As with any procedure requiring general anesthesia, there are small risks of adverse reactions, though serious complications are rare.
The Memory Question
Memory loss is the primary concern that drives patients toward TMS and away from ECT. The fear is understandable, and the concern is valid. Modern ECT techniques have significantly reduced cognitive side effects compared to older methods, but they have not eliminated them. If preserving memory is a top priority for you and your depression is not in the severe or emergent category, TMS is the more conservative first step. If your depression is severe, life-threatening, or has not responded to anything else, the memory trade-off with ECT may be worth accepting for a treatment that could save your life.
Who Qualifies for Each Treatment
TMS Candidacy
- Diagnosis of major depressive disorder
- Failed at least one adequate trial of antidepressant medication (most insurers require at least one failure; some require two or more)
- No metal implants in or near the head (cochlear implants, aneurysm clips, deep brain stimulators, or metallic fragments near the skull are contraindications)
- No history of seizure disorder (relative contraindication)
- No active substance abuse disorder (most clinics require stability)
- Medically stable enough to attend 30+ outpatient sessions over six to nine weeks
ECT Candidacy
- Severe, treatment-resistant depression (usually after failure of multiple medications and possibly TMS)
- Depression with psychotic features
- Catatonia
- Acute suicidality requiring rapid response
- Severe depression in pregnancy (where medication risks are a concern)
- Medical clearance for general anesthesia (cardiac and pulmonary evaluation as needed)
- Willingness to accept potential cognitive side effects
Treatment Protocols and Practical Differences
| Practical Factor | TMS | ECT |
|---|---|---|
| Anesthesia required | No | Yes (general anesthesia each session) |
| Can drive yourself home | Yes | No (someone must drive you) |
| Time off work per session | Minimal (30-60 min total) | Half-day or more (recovery from anesthesia) |
| Total sessions | 36 (standard); 50 (SAINT, condensed to 5 days) | 6-12 acute; then maintenance as needed |
| Treatment duration | 6-9 weeks (standard); 5 days (SAINT) | 3-4 weeks acute |
| Setting | Outpatient psychiatry office | Hospital or ambulatory surgery center |
| During treatment | Awake, can talk, read, or listen to music | Under general anesthesia; no awareness |
Cost and Insurance
TMS costs: $6,000 to $12,000 for a full course of 36 sessions without insurance. Most major insurance plans now cover TMS for treatment-resistant depression, though prior authorization and documentation of medication failures are typically required. Out-of-pocket costs with insurance vary widely depending on your plan. Some clinics offer financing or payment plans.
ECT costs: $25,000 to $50,000+ for a full acute course (including anesthesia, facility fees, and physician charges). Insurance covers ECT for appropriate indications in most cases, but co-pays and deductibles can still be significant. Maintenance ECT adds ongoing costs.
From a pure cost perspective, TMS is substantially less expensive than ECT. When you factor in the lower side effect profile and outpatient convenience, it becomes clear why TMS has become the first-line brain stimulation option for most treatment-resistant depression cases, with ECT reserved for more severe or urgent situations.
Making the Decision
The choice between TMS and ECT is not always straightforward, but a few general principles can guide the conversation:
- Try TMS first if your depression is treatment-resistant but not in the severe or life-threatening category. It is less invasive, has fewer side effects, and does not carry cognitive risk.
- Consider ECT if your depression is severe, involves psychotic features or catatonia, involves active suicidality, or if you have already tried TMS without adequate response.
- Factor in practical constraints: TMS requires 30+ visits to a clinic over six to nine weeks. ECT requires 6 to 12 visits but with anesthesia and recovery time at each. Consider your work schedule, transportation, and support system.
- Discuss the SAINT protocol: If access is available, the SAINT TMS protocol (five days of intensive treatment) may offer a time-efficient alternative to standard TMS with potentially higher remission rates.
- Involve your psychiatrist: A psychiatrist experienced in neuromodulation can assess your specific clinical picture and make a recommendation tailored to your severity, history, and preferences.
Both TMS and ECT have helped people recover from depressions that nothing else could touch. The fact that two effective brain stimulation options exist is genuinely good news for patients who have been stuck in treatment-resistant depression. The key is matching the right treatment to the right patient at the right time.
Related Reading
- TMS Therapy: How It Works and What to Expect
- Ketamine Therapy: A Complete Guide
- Neurofeedback for Anxiety: Can Brain Training Replace Medication?
- Psilocybin Therapy: Current Research and Clinical Applications
Frequently Asked Questions
Which works better for depression, TMS or ECT?
ECT tends to be more effective for the most severe cases and remains the most effective treatment for severe, treatment-resistant depression. Standard TMS has a response rate of 50 to 60 percent and a remission rate of 25 to 35 percent, while ECT has a response rate of 50 to 70 percent (up to 80 percent in some studies) and a remission rate of 30 to 50 percent. The newer SAINT protocol shows promising TMS results, with a reported remission rate around 78 percent.
How much does TMS cost compared to ECT?
A full course of TMS runs about $6,000 to $12,000, while ECT costs roughly $25,000 to $50,000 or more. Most major insurance plans now cover TMS, and insurance covers ECT for appropriate indications in most cases.
What are the main side effects of each treatment?
TMS side effects are mostly mild, including scalp discomfort or pain in 30 to 50 percent of patients and headache in 20 to 30 percent, and it does not cause memory loss, confusion, or measurable cognitive impairment. ECT’s most significant side effect is short-term memory loss, with 10 to 30 percent of patients experiencing persistent memory difficulties, plus post-treatment confusion that usually resolves within an hour and the added risks of general anesthesia. Seizure risk with TMS is less than 0.1 percent.
How long does each treatment take to work?
Standard TMS typically shows results in 2 to 4 weeks, and the SAINT protocol reports results in as little as 5 days. ECT generally works within 1 to 2 weeks. A standard TMS course is 36 sessions over six to nine weeks, while an acute ECT course is 6 to 12 sessions delivered two to three times per week over three to four weeks.
Who is a candidate for TMS versus ECT?
TMS is for people with a major depressive disorder diagnosis who have failed at least one adequate trial of antidepressant medication, with no metal implants near the head and no active substance abuse. ECT is generally reserved for severe, treatment-resistant depression, usually after failure of multiple medications, and requires medical clearance for anesthesia.
Are TMS and ECT FDA approved?
Both TMS and ECT are FDA-cleared treatments for depression. ECT has the largest evidence base of any depression treatment after medication.
